Homology Medicines Inc (FIXX) has released an update to notify the public and investors about a regulation fd disclosure.
Homology Medicines, Inc., Kenobi Merger Sub, Inc., and Q32 Bio Inc. have entered into a Merger Agreement, with Q32 set to become a wholly owned subsidiary of Homology upon completion of the merger. Homology has filed a preliminary proxy statement/prospectus and may file additional documents with the SEC regarding the transaction. The proxy statement/prospectus and other documents filed with the SEC contain important information and will be provided to stockholders. The documents are accessible through the SEC’s website or directly from Homology.
For further insights into FIXX stock, check out TipRanks’ Stock Analysis page.
